Skip to content
Home/Companies/Biotech/Rarity Bioscience

Rarity Bioscience

Biotech·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Rarity Bioscience?

Rarity Bioscience is a Swedish Biotech company, currently owned by Navigare Ventures since 2022.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Navigare Ventures
Investor
Navigare Ventures
Navigare Ventures · 2021 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Navigare Ventures

Other portfolio companies in the same fund.

ScandiEdge
Active
Deep TechSweden· 2026
Basic Genomics
Active
BiotechSweden· 2025
Epigenica
Active
BiotechSweden· 2025
Nordic Forestry Automation
Active
AgTechSweden· 2025
ProteomEdge
Active
BiotechSweden· 2025
Solinide Photonics
Active
Deep TechSweden· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Rarity Bioscience?

Rarity Bioscience is currently owned by Navigare Ventures, through Navigare Ventures, since 2022.

When did Navigare Ventures acquire Rarity Bioscience?

Navigare Ventures acquired Rarity Bioscience in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue